-
1
المؤلفون: G Garcia, C. Chenivesse, Arnaud Bourdin, C. Taille, G Devouassoux
المساهمون: Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), MORNET, Dominique, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
المصدر: Respiratory Medicine and Research
Respiratory Medicine and Research, Elsevier, 2020, 78, pp.100762. ⟨10.1016/j.resmer.2020.100762⟩
Respiratory Medicine and Research, 2020, 78, pp.100762. ⟨10.1016/j.resmer.2020.100762⟩مصطلحات موضوعية: Pulmonary and Respiratory Medicine, 2019-20 coronavirus outbreak, ACT, asthma control test, Coronavirus disease 2019 (COVID-19), SAMA, short acting muscarinic antagonists, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), [SDV]Life Sciences [q-bio], Physical Distancing, Article, ACQ, asthma control questionnaire, NSAIDS, non-steroidal anti-inflammatory drugs, 03 medical and health sciences, 0302 clinical medicine, OCS, oral corticosteroids, Pulmonary Medicine, Medicine, Humans, 030212 general & internal medicine, Anti-Asthmatic Agents, LTRA, leukotriene receptor antagonists, Practice Patterns, Physicians', Pandemics, Societies, Medical, ComputingMilieux_MISCELLANEOUS, 030304 developmental biology, Asthma, 0303 health sciences, business.industry, SARS-CoV-2, Nebulizers and Vaporizers, Outbreak, COVID-19, LAMA, long acting muscarinic antagonists, medicine.disease, Virology, ICS, inhaled corticosteroids, [SDV] Life Sciences [q-bio], Disease Progression, FFP, filtering face-piece, France, business, Public Health Administration, SABA, short acting beta-2 agonists, LABA, long acting beta-2 agonists
وصف الملف: application/pdf